Tin tức & Cập nhật

Chỉ hiển thị Multimedia

Successful endodontic Tx tied to cardiometabolic benefits

28 Jan 2026 bởi

In a self-controlled, longitudinal cohort study on individuals with apical periodontitis (AP), successful endodontic treatment is associated with improvements in glucose tolerance and lipid profile, suggesting a potential role in alleviating cardiometabolic disease risk.

Successful endodontic Tx tied to cardiometabolic benefits

28 Jan 2026

Bariatric surgery, GLP1-RAs effectively reduce fat mass in obese adults

28 Jan 2026 bởi

Among adults with obesity, either bariatric surgery or glucagon-like peptide 1 receptor agonists (GLP-1 RAs), such as semaglutide or tirzepatide, led to substantial fat mass (FM) loss and moderate fat-free mass (FFM) loss, according to a recent study.

Bariatric surgery, GLP1-RAs effectively reduce fat mass in obese adults

28 Jan 2026

Kidney outcomes in T2D better with SGLT2i vs GLP1-RA

27 Jan 2026 bởi

In adults with type 2 diabetes (T2D), treatment with a sodium-glucose cotransporter-2 inhibitor (SGLT2i) confers better protection against chronic and acute kidney events compared with a glucagon-like peptide-1 receptor agonist (GLP-1RA), according to a comparative effectiveness study with a target trial emulation design.

Kidney outcomes in T2D better with SGLT2i vs GLP1-RA

27 Jan 2026

Serum total antioxidant capacity, uric acid tied to obesity in children

26 Jan 2026

Serum uric acid (SUA) and total antioxidant capacity (sTAC) show a positive association with obesity in children, suggests a Mexico study.

Serum total antioxidant capacity, uric acid tied to obesity in children

26 Jan 2026

Berberine of little benefit in individuals with obesity and MASLD

26 Jan 2026

Treatment with berberine in diabetes-free individuals with obesity and metabolic dysfunction–associated steatotic liver disease (MASLD) is safe but falls short of reducing visceral adipose tissue (VAT) and liver fat content, as reported in a study.

Berberine of little benefit in individuals with obesity and MASLD

26 Jan 2026

SGLT2i use improves prognosis in T2D patients with coronary ischaemia

26 Jan 2026 bởi

Use of sodium-glucose cotransporter-2 inhibitors (SGLT2i) reduces 3-year risks of major adverse cardiac events (MACE) and all-cause mortality in patients with type 2 diabetes (T2D) and coronary ischaemia, irrespective of the completeness of revascularization, researchers from the University of Hong Kong (HKU) have reported.

SGLT2i use improves prognosis in T2D patients with coronary ischaemia

26 Jan 2026

Low-dose spironolactone helps regulate blood pressure in primary aldosteronism

23 Jan 2026

Treatment with spironolactone at low doses helps improve blood pressure control in patients with primary aldosteronism, with the added benefit of reduced adverse effects, as shown in a retrospective study.

Low-dose spironolactone helps regulate blood pressure in primary aldosteronism

23 Jan 2026

Serum FT3 levels inversely linked to DPN in euthyroid patients with T2D

23 Jan 2026

Low free triiodothyronine (FT3) is associated with diabetic peripheral neuropathy (DPN) in euthyroid patients with type 2 diabetes (T2D), according to a study.

Serum FT3 levels inversely linked to DPN in euthyroid patients with T2D

23 Jan 2026

Gestational glucose intolerance may raise obesity risk in childhood

23 Jan 2026

Older children and adolescents with exposure to gestational glucose intolerance (GGI)-1 (abnormal value) and gestational diabetes mellitus (GDM) in utero tend to be at greater risk of obesity than those born to normal glucose tolerance (NGT) pregnancies, reports a study, which also accounted for maternal BMI.

Gestational glucose intolerance may raise obesity risk in childhood

23 Jan 2026

Menopause timing, type not linked to diabetes risk

23 Jan 2026

Neither the timing nor type of menopause appears to influence the risk of diabetes, according to a study.

Menopause timing, type not linked to diabetes risk

23 Jan 2026

Tin tức & Cập nhật

Xem bài viết Nội tiết

Xem

Chuyên ngành:

Successful endodontic Tx tied to cardiometabolic benefits

Successful endodontic Tx tied to cardiometabolic benefits

Bariatric surgery, GLP1-RAs effectively reduce fat mass in obese adults

Bariatric surgery, GLP1-RAs effectively reduce fat mass in obese adults

Kidney outcomes in T2D better with SGLT2i vs GLP1-RA

Kidney outcomes in T2D better with SGLT2i vs GLP1-RA

Serum total antioxidant capacity, uric acid tied to obesity in children

Serum total antioxidant capacity, uric acid tied to obesity in children

Berberine of little benefit in individuals with obesity and MASLD

Berberine of little benefit in individuals with obesity and MASLD

SGLT2i use improves prognosis in T2D patients with coronary ischaemia

SGLT2i use improves prognosis in T2D patients with coronary ischaemia

Low-dose spironolactone helps regulate blood pressure in primary aldosteronism

Low-dose spironolactone helps regulate blood pressure in primary aldosteronism

Serum FT3 levels inversely linked to DPN in euthyroid patients with T2D

Serum FT3 levels inversely linked to DPN in euthyroid patients with T2D

Gestational glucose intolerance may raise obesity risk in childhood

Gestational glucose intolerance may raise obesity risk in childhood

Menopause timing, type not linked to diabetes risk

Menopause timing, type not linked to diabetes risk